Research statistics

Nafarelin research: publications and trials

What has been published on Nafarelin: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Nafarelin works or is safe. For what it is and what the studies found, see the Nafarelin profile.
Automated weekly refresh · data through November 1, 2026

At a glance

Publications, all years

352

Since 1981

Publications in 2026 so far

1

Through November 1, 2026

Human clinical research

68.0%

219 of 322 classified

Registered clinical trials

10

ClinicalTrials.gov

Randomized controlled trials

65

Publications reporting an RCT in people

Systematic reviews and meta-analyses

2

Preclinical studies

16.1%

34 animal · 12 in vitro · 6 computational

Records that only mention it

20

Not counted above

Status in the library: FDA-approved. 30 publications are not yet classified by study type.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.

Publications by year

Nafarelin publications by year and evidence

1981, Preclinical (animal, in vitro, computational): 2 of 21983, Preclinical (animal, in vitro, computational): 1 of 11984, Human clinical research: 3 of 91984, Preclinical (animal, in vitro, computational): 5 of 91984, Other and not yet classified: 1 of 91985, Human clinical research: 7 of 141985, Preclinical (animal, in vitro, computational): 6 of 141985, Reviews and meta-analyses: 1 of 141986, Human clinical research: 7 of 111986, Preclinical (animal, in vitro, computational): 2 of 111986, Reviews and meta-analyses: 1 of 111986, Other and not yet classified: 1 of 111987, Human clinical research: 4 of 81987, Preclinical (animal, in vitro, computational): 2 of 81987, Other and not yet classified: 2 of 81988, Human clinical research: 5 of 141988, Preclinical (animal, in vitro, computational): 2 of 141988, Reviews and meta-analyses: 2 of 141988, Other and not yet classified: 5 of 141989, Human clinical research: 12 of 231989, Preclinical (animal, in vitro, computational): 1 of 231989, Reviews and meta-analyses: 2 of 231989, Other and not yet classified: 8 of 231990, Human clinical research: 16 of 251990, Preclinical (animal, in vitro, computational): 1 of 251990, Reviews and meta-analyses: 5 of 251990, Other and not yet classified: 3 of 251991, Human clinical research: 8 of 171991, Preclinical (animal, in vitro, computational): 2 of 171991, Reviews and meta-analyses: 3 of 171991, Other and not yet classified: 4 of 171992, Human clinical research: 11 of 191992, Preclinical (animal, in vitro, computational): 1 of 191992, Reviews and meta-analyses: 4 of 191992, Other and not yet classified: 3 of 191993, Human clinical research: 10 of 151993, Preclinical (animal, in vitro, computational): 2 of 151993, Reviews and meta-analyses: 2 of 151993, Other and not yet classified: 1 of 151994, Human clinical research: 18 of 291994, Preclinical (animal, in vitro, computational): 2 of 291994, Reviews and meta-analyses: 3 of 291994, Other and not yet classified: 6 of 291995, Human clinical research: 14 of 171995, Preclinical (animal, in vitro, computational): 2 of 171995, Other and not yet classified: 1 of 171996, Human clinical research: 12 of 141996, Preclinical (animal, in vitro, computational): 2 of 141997, Human clinical research: 9 of 91998, Human clinical research: 9 of 111998, Reviews and meta-analyses: 2 of 111999, Human clinical research: 9 of 101999, Reviews and meta-analyses: 1 of 102000, Human clinical research: 15 of 202000, Reviews and meta-analyses: 4 of 202000, Other and not yet classified: 1 of 202001, Human clinical research: 10 of 122001, Reviews and meta-analyses: 2 of 122002, Human clinical research: 6 of 62003, Human clinical research: 5 of 102003, Preclinical (animal, in vitro, computational): 4 of 102003, Reviews and meta-analyses: 1 of 102004, Human clinical research: 4 of 52004, Preclinical (animal, in vitro, computational): 1 of 52005, Human clinical research: 3 of 32006, Human clinical research: 2 of 72006, Preclinical (animal, in vitro, computational): 1 of 72006, Reviews and meta-analyses: 3 of 72006, Other and not yet classified: 1 of 72007, Reviews and meta-analyses: 1 of 12008, Human clinical research: 2 of 32008, Reviews and meta-analyses: 1 of 32009, Human clinical research: 4 of 62009, Reviews and meta-analyses: 1 of 62009, Other and not yet classified: 1 of 62010, Human clinical research: 2 of 32010, Preclinical (animal, in vitro, computational): 1 of 32011, Human clinical research: 2 of 32011, Preclinical (animal, in vitro, computational): 1 of 32012, Preclinical (animal, in vitro, computational): 3 of 32013, Human clinical research: 2 of 42013, Preclinical (animal, in vitro, computational): 1 of 42013, Other and not yet classified: 1 of 42014, Human clinical research: 1 of 12015, Human clinical research: 1 of 42015, Preclinical (animal, in vitro, computational): 2 of 42015, Reviews and meta-analyses: 1 of 42016, Human clinical research: 1 of 12017, Human clinical research: 1 of 32017, Preclinical (animal, in vitro, computational): 1 of 32017, Other and not yet classified: 1 of 32020, Human clinical research: 1 of 42020, Preclinical (animal, in vitro, computational): 2 of 42020, Reviews and meta-analyses: 1 of 42023, Preclinical (animal, in vitro, computational): 1 of 12024, Human clinical research: 1 of 22024, Preclinical (animal, in vitro, computational): 1 of 22025, Human clinical research: 1 of 12026 (to date), Human clinical research: 1 of 1Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified010203019811991200020092026*
Counted PubMed publications by year of first publication. * 2026 runs to November 1, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
198102002
198301001
198435019
1985761014
1986721111
198742028
1988522514
19891212823
19901615325
1991823417
19921114319
19931022115
19941823629
19951420117
19961220014
199790009
1998902011
1999901010
20001504120
20011002012
200260006
2003541010
200441005
200530003
200621317
200700101
200820103
200940116
201021003
201121003
201203003
201321014
201410001
201512104
201610001
201711013
202012104
202301001
202411002
202510001
2026 (to date)10001

Study types

Other clinical trial79
Randomized controlled trial65
Observational human study49
Review39
Animal study34
Not yet classified30
Case report26
In vitro study12
Editorial, letter or other10
Computational study6
Meta-analysis1
Systematic review1

Research areas

From MeSH major topics. A paper can be in several areas.

Reproductive and sexual health260
Endocrinology113
Oncology59
Neurological and mental health27
Musculoskeletal25
Metabolic health13
Dermatology11
Antimicrobial and infectious disease5
Gastrointestinal5
Immune system5
Tissue repair2
Cardiovascular1

Registered clinical trials

1 of 3 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 3 · Recruiting: 3 · Unknown status: 2 · Not yet recruiting: 1 · Withdrawn: 1
Early phase 1: 1 · Phase not applicable: 3 · Phase 1 / Phase 2: 1 · Phase 2: 1 · Phase 3: 1 · Phase 4: 3

TrialStatusPhaseStartedResults
Intranasal Nafarelin For Triggering Oocyte MaturationNCT06763926 · 154 enrolledRecruitingPhase 42026-10—
GnRH for Luteal Support - Mechanism of ActionNCT07620067 · 150 enrolledRecruitingPhase not applicable2026-05—
Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus ProgesteroneNCT06870266 · 150 enrolledNot yet recruitingEarly phase 12025-03—
Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI CyclesNCT06150703 · 652 enrolledRecruitingPhase 32024-06—
Injection Free IVFNCT04850261WithdrawnPhase 22021-05—
GnRH Agonist for Luteal Phase Support.NCT05484193 · 150 enrolledUnknown statusPhase not applicable2020-06—
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High RespondersNCT04797338 · 100 enrolledUnknown statusPhase 42017-12—
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro FertilizationNCT02865681 · 4 enrolledCompletedPhase not applicable2016-07—
Natural Versus HRT Cycles in Frozen Embryo Replacement TreatmentNCT00843570 · 159 enrolledCompletedPhase 42009-11—
Endometriosis : Traditional Medicine vs Hormone TherapyNCT00034047 · 50 enrolledCompletedPhase 1, Phase 22002-09—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Efficacy of nafarelin in assisted reproductive technology: a meta-analysis.

    Human reproduction update · January 1, 2001 · Meta-analysis · cited 14 times

    PMID 11212082 · DOI 10.1093/humupd/7.1.92 · Reviews and meta-analyses

  2. Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review.

    Sao Paulo medical journal = Revista paulista de medicina · September 1, 2008 · Systematic review · cited 24 times · open access

    PMID 19099162 · DOI 10.1590/s1516-31802008000500007 · Reviews and meta-analyses

  3. Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.

    Fertility and sterility · November 1, 2013 · Randomized controlled trial · cited 110 times · open access

    PMID 24188873 · DOI 10.1016/j.fertnstert.2013.09.035 · Human clinical research

  4. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.

    BJOG : an international journal of obstetrics and gynaecology · March 29, 2010 · Randomized controlled trial · cited 47 times

    PMID 20353458 · DOI 10.1111/j.1471-0528.2010.02545.x · Human clinical research

  5. Recrudescence of spermatogenesis in the dog following downregulation using a slow release GnRH agonist implant.

    Reproduction in domestic animals = Zuchthygiene · July 1, 2009 · Randomized controlled trial · cited 48 times

    PMID 19754591 · DOI 10.1111/j.1439-0531.2009.01378.x · Human clinical research

  6. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.

    BJOG : an international journal of obstetrics and gynaecology · February 4, 2009 · Randomized controlled trial · cited 35 times

    PMID 19191779 · DOI 10.1111/j.1471-0528.2008.02022.x · Human clinical research

  7. Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study.

    Reproductive biomedicine online · January 1, 2006 · Randomized controlled trial · cited 32 times

    PMID 16454930 · DOI 10.1016/s1472-6483(10)60976-5 · Human clinical research

  8. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.

    Human reproduction (Oxford, England) · October 27, 2005 · Randomized controlled trial · cited 90 times

    PMID 16253978 · DOI 10.1093/humrep/dei302 · Human clinical research

  9. A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan.

    Journal of the Chinese Medical Association : JCMA · July 1, 2005 · Randomized controlled trial · cited 22 times

    PMID 16038370 · DOI 10.1016/s1726-4901(09)70166-2 · Human clinical research

  10. Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density?

    The Journal of reproductive medicine · July 1, 2002 · Randomized controlled trial · cited 13 times

    PMID 12170527 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.

    Pediatrics · March 30, 2009 · Review · cited 820 times · open access

    PMID 19332438 · DOI 10.1542/peds.2008-1783 · Reviews and meta-analyses

  2. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.

    The New England journal of medicine · February 1, 1988 · Randomized controlled trial · cited 361 times

    PMID 2963213 · DOI 10.1056/nejm198802253180805 · Human clinical research

  3. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia.

    The New England journal of medicine · September 1, 1987 · Other clinical trial · cited 338 times

    PMID 2441256 · DOI 10.1056/nejm198709033171004 · Human clinical research

  4. Detection of functional ovarian hyperandrogenism in women with androgen excess.

    The New England journal of medicine · July 1, 1992 · Observational human study · cited 327 times · open access

    PMID 1319000 · DOI 10.1056/nejm199207163270304 · Human clinical research

  5. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.

    The New England journal of medicine · March 1, 1989 · Other clinical trial · cited 311 times

    PMID 2521688 · DOI 10.1056/nejm198903023200904 · Human clinical research

Latest publications

  1. Is there a difference in ovarian hyperstimulation syndrome rates in freeze-all treatment cycles in high-risk patients treated with different GnRH agonist triggers?

    Human fertility (Cambridge, England) · October 5, 2026 · Observational human study · cited 0 times · open access

    PMID 42831293 · DOI 10.1080/14647273.2026.2733078 · Human clinical research

  2. Trends in endometriosis interventions: an interrupted time series analysis following the Australian National Action Plan for Endometriosis (NAPE) 2018.

    Australian health review : a publication of the Australian Hospital Association · August 1, 2025 · Observational human study · cited 0 times · open access

    PMID 40623680 · DOI 10.1071/ah25047 · Human clinical research

  3. A study on the efficacy and safety of long-term adjusted low-dose gonadotropin-releasing hormone agonist therapy for uterine fibroids and adenomyosis.

    The journal of obstetrics and gynaecology research · October 27, 2024 · Observational human study · cited 1 times

    PMID 39462178 · DOI 10.1111/jog.16128 · Human clinical research

  4. Mechanistic Model for Drug Release from PLGA-Based Biodegradable Implants for <i>In Vitro</i> Release Testing: Development and Validation.

    ACS applied bio materials · October 18, 2024 · Computational study · cited 18 times · open access

    PMID 39424342 · DOI 10.1021/acsabm.4c01054 · Computational studies

  5. Anti-Dengue: A Machine Learning-Assisted Prediction of Small Molecule Antivirals against Dengue Virus and Implications in Drug Repurposing.

    Viruses · December 27, 2023 · Computational study · cited 30 times · open access

    PMID 38257744 · DOI 10.3390/v16010045 · Computational studies

  6. Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses.

    Frontiers in veterinary science · August 14, 2020 · Review · cited 31 times · open access

    PMID 32923467 · DOI 10.3389/fvets.2020.00483 · Reviews and meta-analyses

  7. GnRHa for trigger and luteal phase support in natural cycle frozen embryo transfer - A proof of concept study.

    Reproductive biology · July 30, 2020 · Other clinical trial · cited 8 times

    PMID 32741721 · DOI 10.1016/j.repbio.2020.07.009 · Human clinical research

  8. Detection of bioactive peptides including gonadotrophin-releasing factors (GnRHs) in horse urine using ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC/HRMS).

    Drug testing and analysis · July 17, 2020 · Animal study · cited 22 times

    PMID 32558326 · DOI 10.1002/dta.2880 · Animal studies

  9. In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme.

    Journal of biomolecular structure & dynamics · July 1, 2020 · Computational study · cited 37 times

    PMID 32608329 · DOI 10.1080/07391102.2020.1787228 · Computational studies

  10. Caspase-3 gene expression in human luteinized granulosa cells is inversely correlated with the number of oocytes retrieved after controlled ovarian stimulation.

    Human fertility (Cambridge, England) · July 25, 2017 · Observational human study · cited 10 times

    PMID 28738699 · DOI 10.1080/14647273.2017.1356474 · Human clinical research

Browse all 352 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Nafarelin; Nafarelina; Nafareline; Nafarelinum; RS-94991; Synarel

((TITLE_ABS:"Nafarelin" OR CHEM:"Nafarelin") OR (TITLE_ABS:"Nafarelina" OR CHEM:"Nafarelina") OR (TITLE_ABS:"Nafareline" OR CHEM:"Nafareline") OR (TITLE_ABS:"Nafarelinum" OR CHEM:"Nafarelinum") OR (TITLE_ABS:"RS-94991" OR CHEM:"RS-94991" OR TITLE_ABS:"RS94991" OR CHEM:"RS94991") OR (TITLE_ABS:"Synarel" OR CHEM:"Synarel")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 2). Nafarelin research statistics (Version weekly-2026-11-01) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/nafarelin